Mucosa-associated lymphoid tissue (MALT) lymphomas occur in not only the ocular adnexa, but rarely in the sclera or uvea. Histopathological confirmation contributes to a better understanding of the pathogenesi... … [Read more...] about A case of uveoscleral mucosa-associated lymphoid tissue lymphoma with secondary angle-closure glaucoma
News
Early response of anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) management: microperimetry and optical coherence tomography (OCT) findings: a pilot study at national eye center of third world country
To evaluate early response of retinal sensitivity (RS) and retinal morphology in diabetic macular edema (DME) patients after intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment. … [Read more...] about Early response of anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) management: microperimetry and optical coherence tomography (OCT) findings: a pilot study at national eye center of third world country
Q&A: Cure Blindness Project expands reach to prevent blindness
December 26, 2024 4 min read Key takeaways: Cure Blindness Project works in 30 countries in Asia, Sub-Saharan Africa and South America. Since its founding, the organization with partners has performed 1.6 million surgeries and 16.5 million screenings. Nearly 30 years after the organization’s founding, Cure Blindness Project, … [Read more...] about Q&A: Cure Blindness Project expands reach to prevent blindness
Top blogs in ophthalmology for 2024
December 26, 2024 1 min read Healio’s top ophthalmology blogs from 2024 covered topics including dry eye and photophobia, the latest in IOL technology and the use of AI for marketing. Check out this year’s top blog items below. Check out this year’s top blog items below. Image: Adobe Stock BLOG: The FTC’s noncompete ban: What physicians need to know On … [Read more...] about Top blogs in ophthalmology for 2024
Galimedix begins study of GAL-101 eye drops for dry AMD
December 26, 2024 1 min read Galimedix Therapeutics announced the initiation of its phase 2 eDREAM study to assess the safety and efficacy of GAL-101 eye drops in patients with dry age-related macular degeneration, according to a company press release. “GAL-101 eye drops have already shown an excellent safety and tolerability profile in phase 1 clinical testing, and … [Read more...] about Galimedix begins study of GAL-101 eye drops for dry AMD
Ophthalmology Times 2024 wrap-up: A year of innovation and insight
As 2024 comes to a close, we here at Ophthalmology Times and the greater Eye Care Network would like to thank you–the reader. Throughout the year, we have had the privilege of covering a wide range of topics in ophthalmology. As always, stay tuned to see highlights from the year from all other Eye Care Brands on Ophthalmology Times. Now, we take a look back at some of the … [Read more...] about Ophthalmology Times 2024 wrap-up: A year of innovation and insight
VIDEO: New therapies may ‘move the needle’ on treatment of diabetic retinopathy
Source: Ip MS. Update on the current treatment of diabetic retinopathy. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago. Disclosures: Ip reports consulting for Alimera Sciences, Allergan, Amgen, Apellis, Biogen, Cell Lineage, Clearside Biomedical, Genentech, Iveric Biour, Novartis, OccuRx, ONL Therapeutics, Regeneron and Regenxbio. … [Read more...] about VIDEO: New therapies may ‘move the needle’ on treatment of diabetic retinopathy
Advancing Fuchs dystrophy care: Longterm success of descemet stripping only
Fuchs endothelial corneal dystrophy (FECD) is a disease of the corneal endothelium, for which surgical management has evolved greatly over recent decades.As part of the Journal Club series between the NYU Grossman School of Medicine Department of Ophthalmology and Ophthalmology Times, participants will discuss recent impactful papers with visiting faculty members across … [Read more...] about Advancing Fuchs dystrophy care: Longterm success of descemet stripping only
Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
A recent study conducted at Helsinki University Hospital, Finland, examined whether diabetes influences anatomical and functional outcomes following epiretinal membrane (ERM) surgery. The findings suggest that the presence of diabetes, glycemic control, or insulin therapy does not significantly affect postoperative outcomes.The study analyzed data from 214 eyes of 214 … [Read more...] about Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
NYU Ophthalmology Journal Club: Exploring longterm success of DSO for Fuchs Dystrophy with Deepinder Dhaliwal, MD, LAc
Video TranscriptEditor's note –This transcript has been edited for clarity.Rachel Babij, MD, PhD: Hi, I'm Dr. Rachel Babij, one of the residents here at NYU Department of Ophthalmology, and we're here for an installment of NYU Department of Ophthalmology Journal Club, where we will be sitting down with leaders in the field to discuss some of their recent work. Today, I'm here … [Read more...] about NYU Ophthalmology Journal Club: Exploring longterm success of DSO for Fuchs Dystrophy with Deepinder Dhaliwal, MD, LAc